<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01887067</url>
  </required_header>
  <id_info>
    <org_study_id>HKEC-2012-038</org_study_id>
    <nct_id>NCT01887067</nct_id>
  </id_info>
  <brief_title>Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus</brief_title>
  <acronym>HTN2DM</acronym>
  <official_title>Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamela Youde Nethersole Eastern Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamela Youde Nethersole Eastern Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate the efficacy of renal denervation therapy in treating resistant hypertension
      and its effect on glucose metabolism in patients with type 2 diabetes mellitus
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in office systolic &amp; diastolic blood pressure from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in office systolic and diastolic blood pressure up to 3 years</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin sensitivity</measure>
    <time_frame>12 months</time_frame>
    <description>HOMA-IR index at baseline, 3-month and 12-month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in glucose metabolism</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Hypertension, Resistant</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Renal Denervation Therapy</condition>
  <arm_group>
    <arm_group_label>Renal denervation therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Renal denervation therapy</intervention_name>
    <arm_group_label>Renal denervation therapy</arm_group_label>
    <other_name>Renal denervation using Symplicity® Catheter System™</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ranges from 18 to 70 years inclusive

          -  Essential hypertension

          -  Office Systolic BP (SBP) ≥ 150 mmHg or Diastolic BP (DBP) ≥ 90mmHg

          -  3 or more anti-hypertensive medications of different classes, including a diuretic, or
             documented intolerance to multiple medications

          -  Type 2 Diabetes Mellitus on oral hypoglycaemic agent (OHA)

          -  2 functional kidneys; eGFR ≥ 45 mL/min/1.73m² (MDRD formula)

          -  Suitable renal anatomy compatible with the endovascular denervation procedure

        Exclusion Criteria:

          -  Individual has renal artery anatomy that is ineligible for treatment including:

          -  Patients with secondary hypertension

          -  Myocardial infarction, unstable angina pectoris, cerebrovascular accident within 6
             months

          -  Patient with type 1 diabetes mellitus

          -  Patient on insulin due to oral drug failure

          -  Renovascular abnormalities (including severe renal artery stenosis, previous renal
             stenting or angioplasty, or known dual renal arteries)

          -  Pregnancy

          -  Patient with any implantable device incompatible with radiofrequency energy delivery

          -  Hemodynamically significant valvular heart disease for which reduction of BP would be
             considered hazardous

          -  Any serious medical condition, which in the opinion of the investigator, may limit the
             life expectancy of patients or adversely
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kin Lam Tsui, FRCP (Edin, Glasg)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pamela Youde Nethersole Eastern Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kin Lam Tsui, FRCP (Edin, Glasg)</last_name>
    <phone>+852 25956412</phone>
    <email>tsuikl1@ha.org.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pamela Youde Nethersole Eastern Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kin Lam Tsui, FRCP (Edin, Glasg)</last_name>
      <phone>+852 25956412</phone>
      <email>tsuikl1@ha.org.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2013</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamela Youde Nethersole Eastern Hospital</investigator_affiliation>
    <investigator_full_name>Kin Lam TSUI</investigator_full_name>
    <investigator_title>Consultant Physician</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

